Aller au contenu principal
Profil bibliographique

G. Villani

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

14Publications signalées
103Citations signalées
0Affiliations récentes

Les domaines associés

Cancer Treatment and PharmacologyAnesthesia and Pain ManagementAnesthesia and Sedative AgentsOpioid Use Disorder TreatmentMeningioma and schwannoma management

Les publications récentes

Accès ouvert 2022 article OpenAlex

Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy

Giacomo Grasselli, Alberto Zanella, Eleonora Carlesso, Gaetano Florio et autres

Importance: Data on the association of COVID-19 vaccination with intensive care unit (ICU) admission and outcomes of patients with SARS-CoV-2-related pneumonia are scarce. Objective: To evaluate whether COVID-19 vaccination is associated with preventing ICU admission for COVID-19 pneumonia and to compare baseline …

it (code pays fourni par la source)

46 citations JAMA Network Open
2022 conference-abstract OpenAlex

P355 Exceeding treatment expectations in Crohn’s disease: transmural healing and a new definition of deep remission

Fabiana Castiglione, Nicola Imperatore, Anna Testa, Roberto de Sire et autres

Abstract Background While mucosal (MH) and transmural healing (TH) predict relevant clinical outcomes in Crohn’s disease (CD), little is known about the real significance and clinical impact of deep remission (DR). The aim of this study was to better explore the concept …

0 citations Journal of Crohn s and Colitis
Accès ouvert 2017 conference-abstract OpenAlex

P09.41 Single agent Bevacizumab in recurrent glioblastoma after a second line chemotherapy with Fotemustine. The Italian Association of Neuro Oncology experience

Alessandra Gonnelli, MARTINA CANTARELLA, Anna Lia Molinari, G. Villani et autres

Bevacizumab is an anti-VEGF antibody used in the treatment of recurrent glioblastoma (GBM). Despite the available literature, few is known about the best schedule to administer this angiogenesis inhibitor: i) early, at the first recurrence, or ii) later, after a second line …

it (code pays fourni par la source)

0 citations Neuro-Oncology
Accès ouvert 2015 article OpenAlex

Une première anthologie verlainienne

G. Villani

­L'article a pour sujet ­l'anthologie établie à la fin du xixe siècle par Vittorio Pica sur Verlaine. Il montre que Pica institue son anthologie, réglée sur les étapes de ­l'existence du poète, sur le modèle ­d'un canzionere.

0 citations Classiques GARNIER
2011 book-chapter OpenAlex

Paving the Way to an Effective and Efficient Retrieval of Data over Semantic Overlay Networks

Federica Mandreoli, Riccardo Martoglia, Wilma Penzo, Simona Sassatelli et autres

In a Peer-to-Peer (P2P) system, a Semantic Overlay Network (SON) models a network of peers whose connections are influenced by the peers’ content, so that semantically related peers connect with each other. This is very common in P2P communities, where peers share …

it (code pays fourni par la source)

1 citation IGI Global eBooks
2000 article OpenAlex

Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).

Salvatore Toma, Aniello Tucci, G. Villani, Giacomo Cartenì et autres

BACKGROUND: Doxorubicin remains one of the few drugs with consistent single agent activity in advanced Soft Tissue Sarcomas (STS), with a demonstrated dose-response relationship. Liposomal-encapsulated Doxorubicin (LED) has been shown to be at least as active as free doxorubicin in experimental models, …

gb, it (code pays fourni par la source)

49 citations PubMed

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.